Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

STEP: Proglide® Versus Femoseal®: A Randomized Controlled Trial to Compare the Efficacy of Arterial Closure Devices Following Endovascular Peripheral Arterial Procedures

NCT03192033 is registered in ClinicalTrials.gov with Nantes University Hospital as lead sponsor.

NCT NCT03192033
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03192033 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
STEP: Proglide® Versus Femoseal®: A Randomized Controlled Trial to Compare the Efficacy of Arterial Closure Devices Following Endovascular Peripheral Arterial Procedures
Lead sponsor
Nantes University Hospital
Phase
Not applicable
Overall status
Completed
Start date
December 4, 2017
Completion date
June 25, 2019
Enrollment
233 (actual)
Sites
6

Conditions

As the registry lists them; a condition with its own page is linked.

peripheral arterial disease